| 000 | 01801cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030658.0 | ||
| 008 | 120929s2012 ua f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.06.M.Sc.2012.Al.E | ||
| 100 | 0 | _aAli Mohammed Ali Mohammed | |
| 245 | 1 | 0 |
_aEvaluation of viability of BCG vaccine using a conventional viable count method and a tetrazolium salt rapid assay method / _cAli Mohammed Ali Mohammed ; Supervised Ali Mohamed Kholefy , Hamdallah Hafez Zedan |
| 246 | 1 | 5 | _aبالطريقة التقليدية و الطريقة السريعة باستخدام ملح التترازوليوم BCG دراسة حيوية لقاح |
| 260 |
_aCairo : _bAli Mohammed Ali Mohammed , _c2012 |
||
| 300 |
_a146 P. ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Microbiology and Immunology | ||
| 520 | _aThe potency of the live attenuated Mycobacterium bovis BCG vaccine is dependent on its content of viable cell. The viability of the organism is essential for the stimulayion of a protective immune response, hence monitoring of the viable count is an integral part of quality control o BCG vaccine. The method, which is recommended by the world health organization (WHO) and European Pharmacopoeia (EP) for control of potency of BCG vaccine, is the conventional viable count | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBCG vaccine | |
| 653 | 4 | _aTetrazolium salts | |
| 653 | 4 | _aViability | |
| 700 | 0 |
_aAli Mohamed Kholefy , _eSupervisor |
|
| 700 | 0 |
_aHamdallah Hafez Zedan , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c39684 _d39684 |
||